In 2004 the company acquired STEAG microParts GmbH. In December of the same year the company announced the acquisition of the outstanding shares of Boehringer Ingelheim Shionogi Vetmedica. In June 2008, the company announced its intention to acquire Actimis Pharmaceuticals ...
Boehringer Ingelheim is a global, research-driven pharmaceutical company embracing many cultures and diverse societies.
Innovative medicines for people and animals have for more than 130 years been what the research-driven pharmaceutical company Boehringer Ingelheim stands for. Boehringer Ingelheim is one of the pharmaceutical industry's top 20 companies and to this day remains family-owned. Day by day, some 50,000 employees ...
Boehringer Ingelheim is one of the world's 20 leading pharmaceutical companies . Since its founding in 1885, the family-owned company has been committ.
Boehringer Ingelheim Pharmaceuticals, Inc. 900 Ridgebury Road Ridgefield, CT 06877. Phone: 1-800-243-0127 (toll free) Phone: 203-798-9988. Fax: 203-791- 6234. Boehringer Ingelheim Pharmaceuticals, Inc. 900 Ridgebury Rd, P.O. Box 368. Ridgefield, CT 06877-0368. Phone: 1-800-243-0127. TTY : 1-800-246-6196 ...
Boehringer Ingelheim Pharmaceuticals, Inc. manufactures, markets and/or distributes more than 34 drugs in the U.S..
Boehringer Ingelheim Pharmaceuticals, Inc. offers human prescription medicines for the treatment of lung health, cardiovascular diseases, men's prostate health, and anti-viral therapy. Its products include angiotensin II receptor blocker Micardis tablets for cardiovascular causes; and COMBIVENT RESPIMAT, an inhaler for ...
For more than 130 years, Boehringer Ingelheim has been committed to the research, development, and manufacturing of new medications with high therapeutic value for people and animals. As a family-owned pharmaceutical company, Boehringer Ingelheim is able to take a long-term view and invest heavily in research ...
Boehringer Ingelheim Vetmedica animal health website.